CUBE vs HAE · P/E 25, rev $1.07B vs P/E 35, rev $1.36B
CubeSmart (CUBE) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the CUBE and HAE stock pages for the full models.
Not investment advice.